13D·WATCH Activist + Insider Intelligence Live feed Blog About Pilot
SCHEDULE Filed 2025-06-04 Event 2025-06-03 SEC 0000950170-25-081739 →

GKCC, LLC Elicio Therapeutics, Inc. ELTX

Stake: 48.00% Shares: 9,764,864 CUSIP: 28657F103 Class: Common Stock, par value $0.01 per share

Item 4 — Purpose of Transaction

Item 4 is hereby amended and supplemented as follows: The response to Item 3 of this Schedule 13D is incorporated by reference herein.

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
3 13D/G filings on this issuer
2 other filings besides this one
Filer Track Record
2 filings by this filer
1 other filing in the data moat
Short Interest · settle 2026-03-31
DTC 11.57
1,311,845 shares short · +1.8% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers
1 holder · $93K
Point72 Asset Mgmt

Other 13D/G Filings on Elicio Therapeutics, Inc.

FiledFormFilerStakeShares
2025-03-07 SCHEDULE Chudnovsky Yekaterina 48.10% 9,657,539 view →
2024-07-02 SC GKCC, LLC view →

Other Filings by GKCC, LLC

FiledFormIssuerStakeShares
2024-07-02 SC Elicio Therapeutics, Inc. ELTX view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →